Please select the check box at the bottom of this page to confirm that you have read this page and wish to continue.

Identifying and Responding to Substance Use among Adolescents and Young Adults

Release date: December 2016
Expiration Date: August 15, 2018

This Module is approved for 1.5 AMA PRA Category 1 Credit(s)™.

Objectives
At the end of this activity, physicians should be able to: 
1. Recognize the importance of prevention, including screening and early intervention, for the adolescent and young adult population
2. Differentiate the limitations of current tools and curricula that have been developed and validated
3. Explain the scope of the problem related to substance use among adolescents and young adults
4. Apply current models of identifying and responding to substance use among adolescents and young adults
5. Practice the recommended actions for medical providers to address the need for prevention of risky substance use, including screening and early intervention

Target Audience
This activity is designed to meet the educational needs of all addiction medicine physicians, primary care providers (IM, FM, Pediatric/Adolescent Med, Obstetrics & Gynecology), Emergency Medicine, Preventive Medicine, Psychiatry.
  
Statement of Need
One in 6 people in the U.S. age 12 and older meets medical criteria for addiction. Another 1/3 of the population engages in use of addictive substances in ways that can threaten their health and safety or that of others. Risky substance use and addiction constitute the largest preventable and the most costly health problems in the country. In more than 9 out of 10 cases, addiction is a pediatric disease originating with or triggered by substance use before the age of 21, while the brain is still developing. Those who use addictive substances prior to age 15 are six-and-a-half times as likely to develop addiction as those who delay use until age 21 or older (28.1 percent vs. 4.3 percent). Because of the high prevalence of the disease of addiction and the wide-ranging health and social consequences that can result from it and from risky use of addictive substances that does not meet the threshold of addiction, physicians and health care providers should have access to resources to assist with education, screening, and early intervention for adolescents and young adults in order to prevent addiction and other health and social consequences.
  

Statement of Competency
This compendium has been designed to assist physicians and other health care professionals to gain competence by identifying resources for medical practice in which health care providers can prevent and respond to substance use among adolescent and young adults. A pre-test and post-test will assess the learners’ comprehension of the materials and messaging.

Accreditation Statement
The American Society of Addiction Medicine designates this Journal based activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the American Society of Addiction Medicine and the American Board of Addiction Medicine.

The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Successful Completion of CME Activity
Learners are required to complete the pre-test, read all of the accompanying materials and complete the course evaluation to earn full credit for this activity.

Minimum Performance Attainment Level of Achievement
Learners must achieve a passing score of 80% to receive full credit.

Continuing Medical Education (CME) Credits
After successfully passing the Self-Assessment Examinations, Diplomates will earn 1.5 AMA PRA Category 1 Credit(s)™ from the American Society of Addiction Medicine (ASAM). Diplomates can print a Completion of CME Certification on satisfactory completion of the Self-Assessment Activity from the ABAM Web Portal.

Commercial Support
This activity was funded in part by a grant from the Conrad N. Hilton Foundation.

Activity Planning Committee Disclosures
Hoover Adger, Jr., MD, MPH, MBA
No disclosures

Lia Bennett, MPH
No disclosures

Andrew Danzo
No disclosures

Susan Foster, MSW
No disclosures

Kevin Kunz, MD, MPH
No disclosures

Sharon Levy, MD, MPH
No disclosures

Michelle Lyons, MA
No disclosures

ASAM CME Committee Disclosure Listing
Adam J. Gordon, MD, MPH, FACP, FASAM
Chair, ASAM CME Committee
No disclosures

Edwin A. Salsitz, MD, Co-Chair, Activity Reviewer
No disclosures

Catherine Friedman, MD
No disclosures

Noel Ilogu, MD, MRCP, FASAM
No disclosures

Herbert L. Malinoff, MD, FACP, Reviewer
No disclosures

John C. Tanner, DO, FASAM
Reckitt-Benckiser – Honorarium, Speaker and consultant
OREXO - Honorarium, Speaker
Bio Delivery - Honorarium, Speaker

No other individuals involved in the planning, review or delivery of this content have any relevant relationships to disclose. 

Should you have any questions regarding this activity please contact The Addiction Medicine Foundation at 301-656-3378.